Novartis looks to grow global CDMO unit after pandemic pacts put its strengths on displaynews2022-05-17T11:18:31+00:00May 17th, 2022|Fierce Pharma|
Quickly turning $23M into $10M, Zealand offloads insulin delivery tech to MannKindnews2022-05-17T10:46:20+00:00May 17th, 2022|Fierce Pharma|
Pharma marketers: Rural patients have a digital connection but want a human one, toonews2022-05-17T09:42:43+00:00May 17th, 2022|Fierce Pharma|
Gilead HIV prospect escapes FDA hold after glass compatibility glitch triggered regulatory setbacksnews2022-05-17T03:03:39+00:00May 17th, 2022|Fierce Pharma|
Gardasil vaccine maker Merck appeals to parents of 9-year-olds in latest HPV awareness adnews2022-05-16T19:33:43+00:00May 16th, 2022|Fierce Pharma|
Emergent boosts countermeasures repertoire with $325M deal for smallpox newcomer Tembexanews2022-05-16T17:54:10+00:00May 16th, 2022|Fierce Pharma|
GlaxoSmithKline is no more: Meet the scaled down ‘GSK’news2022-05-16T16:58:00+00:00May 16th, 2022|Fierce Pharma|
RDT inks deals to push oral film tech to COVID-19 vaccine firmsnews2022-05-16T15:20:03+00:00May 16th, 2022|Fierce Pharma|
J&J program adds Ena’s infectious disease nasal spray to rosternews2022-05-16T15:14:16+00:00May 16th, 2022|Fierce Pharma|
Moderna may claw back $700,000 salary from Gomez after his 1-day staynews2022-05-16T15:06:58+00:00May 16th, 2022|Fierce Pharma|
